PPARG and Alzheimer disease: Recently, the anti-inflammatory and neuroprotective effects of PPAR-γ ligands coupled with the advantages of nanotechnology-based drug delivery systems have come to represent a breadth of new possibilities in the treatment of AD [5,44,45].